Pre-Test Cutaneous Lupus Erythematosus: Strategies for Diagnosis, Treatment, and Interdisciplinary Management Pre-Test Which of the following subtypes occurs in a transient nature on areas of the skin that are predominantly exposed to UV radiation or can appear as a general rash? Acute CLE Subacute CLE Chronic CLE Discoid LE Unsure Which of the following agents targets ILT7 and is under investigation for CLE and DLE? Afimetoran Branebutinib Daxdilimab Iberdomide Unsure Patient-reported outcomes, such as health-related quality of life and patient global assessment of disease, should be evaluated at what point(s) during treatment? As a baseline parameter during initial visits As a follow-up evaluation after successful treatment initiation During initial baseline visits and at treatment follow-ups If no improvement is seen after treatment initiation Unsure How confident are you in your ability to implement novel treatment strategies to improve patient outcomes? Very Confident Confident Somewhat confident Not very confident Not at all confident How confident are you in your ability to identify and diagnose CLE subtypes? Very Confident Confident Somewhat confident Not very confident Not at all confident
